References
- Kramer P., Sizzo W., Twiss E.E. Nephrotic syndrome in Hodgkin disease. Neth, J. Med. 1981; 24: 114–119
- Moulin B., Ronco P.M., Mougenot B., Francois A., Fillastre J.P., Mignon F. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney International 1992; 42: 127–135
- Gallo G., Buxbaum J. Monoclonal immunoglobulin deposition disease: immunopathologic aspects of renal involvement. The kidney in plasma cell dyscrasias, L Minetti, G d'Amico, C. Ponticelli. Kluwen Academic ed., Dordrecht 1988; 31–43
- Dosa S., Phillips T.M., Antonovych T.T., Segal A., Guha A., Thomson A.M. Acute myelomonocytic leukemia associated with nephrotic syndrome. Nephron 1983; 34: 125–129
- Sudholt B.A., Heironismus J.D. Chronic myelogenous leukemia with nephrotic syndrome. Arch. Intern. Med. 1983; 143: 168–169
- Mufti G.J. A guide to risk assessment in the primary myelodysplastic syndrome. Hematol. Oncol. Clin, N. Am. 1192; 6: 587–606
- Paydas S., Tuncer I., Zorludemir S., Gonlusen G. A case with membranous glomerulonephritis and myelodysplastic syndrome. Nephron. 1992; 62: 231–232
- Fenaux P., Beuscart R., Lai J.L., Jouet J.P., Bauters F. Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. J. Clin. Onc. 1988; 6: 1417–1424
- Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Gatton D., Gralnick H., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haemutol. 1982; 51: 189–199
- Worsley A., Oscier D., Stevens J., Hamblin T. Prognostic features of chronic myelomonocytic leukemia: a modified Bournemouth score gives the best prediction of survival. Br. J. Haematol. 1988; 68: 17–21
- Hamblin T. Immunologic abnormalities in myelodysplastic syndromes. Hematol. Oncol. Clin. North Am. 1992; 6: 571–586
- Mufti G.J., Figes A., Hamblin T.I. Immunological abnormalities in myelodysplastic syndromes, I. Serum immunoglobulins and autoantibodies. Br. J. Haematol. 1986; 63: 143–147
- Morel P., Hebbar M., Lai J.L., Duhamel A., Preudhomme C., Wattel E., Bauters F., Fenaux F. Cytogenetic analysis has strong independant prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993; 7: 1315–1323
- Osserman E.F., Lawlor D.P. Serum and urinary lysozyme (muramidase) in monocyte and myelomonocytic leukemia. J. Ex. Med. 1966; 128: 921–926
- Pruzanski W., Platts M.E. Serum and urinary proteins lysozyme and renal dysfunction in mono and myelomonocytic leukemia. J. Clin. Invest. 1970; 49: 1694–1708
- Lavie G., Zucker-Franklin D., Franklin E.C. Degradation of serum amyloïd A protein by surface-associated enzymes of human blood monocytes. J. Exp. Med. 1978; 148: 1020–1031
- Kyle R., Greipp P.R. Amyloïdosis (AL). Mayo Clin. Proc. 1983; 58: 665–683